Elite hammertime coming SeaQuesTOX FAILED for the last time. Lot's more CRL's on the way. Measly Isradipine IF it passed the study won't help. Not much of a market for that. Too many companies will pull theirs from discontinued use. Besides one needs to read your posts and USING POWER OF DEDUCTION to analyze the OVER INFLATED NUMBERS and reduce them by 90%-99%.
Those new number would be the actual market capture of all of the products "IF" they got approved. HUGE "IF".